Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2008; 100(04): 718-721
DOI: 10.1160/TH08-04-0250
DOI: 10.1160/TH08-04-0250
Letters to the Editor
D-dimer testing and recurrent venous thromboembolism after unprovoked pulmonary embolism: A post-hoc analysis of the prolong extension study
Authors
Further Information
Publication History
Received
22 April 2008
Accepted after major revision
13 July 2008
Publication Date:
22 November 2017 (online)
-
References
- 1 Buller HR, Agnelli G, Hull RD. et al. Antithrombotic therapy for venous thromboembolic disease. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 401S-428S.
- 2 Prandoni P, Lensing AW, Prins MH. et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med 2002; 137: 955-960.
- 3 Piovella F, Crippa L, Barone M. et al. Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with recurrence and new thrombosis. Haematologica 2002; 87: 515-522.
- 4 Palareti G, Legnani C, Cosmi B. et al. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anti-coagulation is stopped. Thromb Haemost 2002; 87: 7-12.
- 5 Palareti G, Legnani C, Cosmi B. et al. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia. Circulation 2003; 108: 313-318.
- 6 Eichinger S, Minar E, Bialonczyk C. et al. D-dimer levels and risk of recurrent venous thromboembolism. J Am Med Assoc 2003; 290: 1071-1074.
- 7 Palareti G, Cosmi B, Legnani C. et al. D-dimer testing to determine the duration of anticoagulation Therapy. N Engl J Med 2006; 355: 1780-1789.
- 8 Palareti G, Leali N, Coccheri S. et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (IS-COAT ): Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996; 348: 423-428.
- 9 Agnelli G, Prandoni P, Becattini C. et al. for the WODIT investigators: Extended oral anticoagulant therapy after a first episode of pulmonary embolism. Ann Intern Med 2003; 139: 19-25.
- 10 Eichinger S, Weltermann A, Minar E. et al. Symptomatic pulmonary embolism and the risk of recurrent venousthromboembolism. Arch Intern Med 2004; 164: 92-96.
- 11 Pengo V, Lensing AW, Prins MH. et al. for the Thromboembolic pulmonary hypertension study group: Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004; 350: 2257-2264.
- 12 Murin S, Romano PS, White RH. Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism. Thromb Haemost 2002; 88: 407-414.
- 13 Kearon C, Gent M, Hirsh J. et al. A comparison of three months of anticoagulation with extended anti-coagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999; 340: 901-907.
- 14 Douketis JD, Kearon C, Bates S. et al. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. J Am Med Assoc 1998; 279: 458-462.
- 15 Agnelli G, Prandoni P, Santamaria MG. et al. for the Wodit investigators: Three months versus one year of oral anticoagulant therapy for idiopathic deep vein thrombosis. N Engl J Med 2001; 345: 165-169.